Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue

1.5 Market Analysis by Type

1.5.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Over-the-counter (OTC) Testing Kits

1.5.3 Prescription-based Testing Kits

1.6 Market by Application

1.6.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2022-2027

1.6.2 Bacterial Infections

1.6.3 Fungal Infection

1.6.4 Virus Infection

1.6.5 Cardiovascular Infection

1.6.6 Gastrointestinal Infection

1.6.7 Sexually Transmitted Disease (STD) Infection

1.6.8 Central Nervous System Infection

1.6.9 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Infectious Disease Point of Care Diagnostics Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Infectious Disease Point of Care Diagnostics Market Players Profiles

3.1 Abbott

3.1.1 Abbott Company Profile

3.1.2 Abbott Infectious Disease Point of Care Diagnostics Product Specification

3.1.3 Abbott Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Roche

3.2.1 Roche Company Profile

3.2.2 Roche Infectious Disease Point of Care Diagnostics Product Specification

3.2.3 Roche Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Accriva

3.3.1 Accriva Company Profile

3.3.2 Accriva Infectious Disease Point of Care Diagnostics Product Specification

3.3.3 Accriva Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Siemens

3.4.1 Siemens Company Profile

3.4.2 Siemens Infectious Disease Point of Care Diagnostics Product Specification

3.4.3 Siemens Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Diasorin

3.5.1 Diasorin Company Profile

3.5.2 Diasorin Infectious Disease Point of Care Diagnostics Product Specification

3.5.3 Diasorin Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 GE Healthcare

3.6.1 GE Healthcare Company Profile

3.6.2 GE Healthcare Infectious Disease Point of Care Diagnostics Product Specification

3.6.3 GE Healthcare Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 BD

3.7.1 BD Company Profile

3.7.2 BD Infectious Disease Point of Care Diagnostics Product Specification

3.7.3 BD Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 BioMerieux

3.8.1 BioMerieux Company Profile

3.8.2 BioMerieux Infectious Disease Point of Care Diagnostics Product Specification

3.8.3 BioMerieux Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Terumo

3.9.1 Terumo Company Profile

3.9.2 Terumo Infectious Disease Point of Care Diagnostics Product Specification

3.9.3 Terumo Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Danaher Corporation

3.10.1 Danaher Corporation Company Profile

3.10.2 Danaher Corporation Infectious Disease Point of Care Diagnostics Product Specification

3.10.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Eiken Chemical

3.11.1 Eiken Chemical Company Profile

3.11.2 Eiken Chemical Infectious Disease Point of Care Diagnostics Product Specification

3.11.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Euroimmun

3.12.1 Euroimmun Company Profile

3.12.2 Euroimmun Infectious Disease Point of Care Diagnostics Product Specification

3.12.3 Euroimmun Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Bio-Rad Laboratories

3.13.1 Bio-Rad Laboratories Company Profile

3.13.2 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Specification

3.13.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Hologic

3.14.1 Hologic Company Profile

3.14.2 Hologic Infectious Disease Point of Care Diagnostics Product Specification

3.14.3 Hologic Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 EMD Millipore

3.15.1 EMD Millipore Company Profile

3.15.2 EMD Millipore Infectious Disease Point of Care Diagnostics Product Specification

3.15.3 EMD Millipore Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Diaxonhit

3.16.1 Diaxonhit Company Profile

3.16.2 Diaxonhit Infectious Disease Point of Care Diagnostics Product Specification

3.16.3 Diaxonhit Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Cavidi

3.17.1 Cavidi Company Profile

3.17.2 Cavidi Infectious Disease Point of Care Diagnostics Product Specification

3.17.3 Cavidi Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.18 Gold Standard Diagnostics

3.18.1 Gold Standard Diagnostics Company Profile

3.18.2 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Specification

3.18.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.19 Epitope Diagnostic

3.19.1 Epitope Diagnostic Company Profile

3.19.2 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Specification

3.19.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.20 Cepheid

3.20.1 Cepheid Company Profile

3.20.2 Cepheid Infectious Disease Point of Care Diagnostics Product Specification

3.20.3 Cepheid Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.21 Immunetics

3.21.1 Immunetics Company Profile

3.21.2 Immunetics Infectious Disease Point of Care Diagnostics Product Specification

3.21.3 Immunetics Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.22 InBios International

3.22.1 InBios International Company Profile

3.22.2 InBios International Infectious Disease Point of Care Diagnostics Product Specification

3.22.3 InBios International Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Infectious Disease Point of Care Diagnostics Market Competition by Market Players

4.1 Global Infectious Disease Point of Care Diagnostics Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Market Players (2016-2021)

4.3 Global Infectious Disease Point of Care Diagnostics Average Price by Market Players (2016-2021)

5 Global Infectious Disease Point of Care Diagnostics Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.1.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2016-2021)

5.1.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.1.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.2.2 Infectious Disease Point of Care Diagnostics Key Players in East Asia (2016-2021)

5.2.3 East Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.2.4 East Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.3.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2016-2021)

5.3.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.3.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.4.2 Infectious Disease Point of Care Diagnostics Key Players in South Asia (2016-2021)

5.4.3 South Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.4.4 South Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.5.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.5.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.6.2 Infectious Disease Point of Care Diagnostics Key Players in Middle East (2016-2021)

5.6.3 Middle East Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.6.4 Middle East Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.7.2 Infectious Disease Point of Care Diagnostics Key Players in Africa (2016-2021)

5.7.3 Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.7.4 Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.8.2 Infectious Disease Point of Care Diagnostics Key Players in Oceania (2016-2021)

5.8.3 Oceania Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.8.4 Oceania Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.9.2 Infectious Disease Point of Care Diagnostics Key Players in South America (2016-2021)

5.9.3 South America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.9.4 South America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Infectious Disease Point of Care Diagnostics Market Size (2016-2021)

5.10.2 Infectious Disease Point of Care Diagnostics Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)

5.10.4 Rest of the World Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)

6 Global Infectious Disease Point of Care Diagnostics Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Infectious Disease Point of Care Diagnostics Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Infectious Disease Point of Care Diagnostics Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Infectious Disease Point of Care Diagnostics Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Infectious Disease Point of Care Diagnostics Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Infectious Disease Point of Care Diagnostics Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Infectious Disease Point of Care Diagnostics Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Infectious Disease Point of Care Diagnostics Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Infectious Disease Point of Care Diagnostics Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Infectious Disease Point of Care Diagnostics Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Infectious Disease Point of Care Diagnostics Consumption by Countries

7 Global Infectious Disease Point of Care Diagnostics Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Infectious Disease Point of Care Diagnostics (2022-2027)

7.2 Global Forecasted Revenue of Infectious Disease Point of Care Diagnostics (2022-2027)

7.3 Global Forecasted Price of Infectious Disease Point of Care Diagnostics (2022-2027)

7.4 Global Forecasted Production of Infectious Disease Point of Care Diagnostics by Region (2022-2027)

7.4.1 North America Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.3 Europe Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.7 Africa Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.9 South America Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Infectious Disease Point of Care Diagnostics Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Application (2022-2027)

8 Global Infectious Disease Point of Care Diagnostics Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.2 East Asia Market Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.3 Europe Market Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Countriy

8.4 South Asia Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.5 Southeast Asia Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.6 Middle East Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.7 Africa Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.8 Oceania Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.9 South America Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

8.10 Rest of the world Forecasted Consumption of Infectious Disease Point of Care Diagnostics by Country

9 Global Infectious Disease Point of Care Diagnostics Sales by Type (2016-2027)

9.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2016-2021)

9.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2022-2027)

10 Global Infectious Disease Point of Care Diagnostics Consumption by Application (2016-2027)

10.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2016-2021)

10.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2022-2027)

11 Global Infectious Disease Point of Care Diagnostics Manufacturing Cost Analysis

11.1 Infectious Disease Point of Care Diagnostics Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Infectious Disease Point of Care Diagnostics

12 Global Infectious Disease Point of Care Diagnostics Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Infectious Disease Point of Care Diagnostics Distributors List

12.3 Infectious Disease Point of Care Diagnostics Customers

12.4 Infectious Disease Point of Care Diagnostics Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue (US$ Million) 2016-2021

Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Type (US$ Million): 2022-2027

Table 7. Over-the-counter (OTC) Testing Kits Features

Table 8. Prescription-based Testing Kits Features

Table 16. Global Infectious Disease Point of Care Diagnostics Market Size by Application (US$ Million): 2022-2027

Table 17. Bacterial Infections Case Studies

Table 18. Fungal Infection Case Studies

Table 19. Virus Infection Case Studies

Table 20. Cardiovascular Infection Case Studies

Table 21. Gastrointestinal Infection Case Studies

Table 22. Sexually Transmitted Disease (STD) Infection Case Studies

Table 23. Central Nervous System Infection Case Studies

Table 24. Other Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Infectious Disease Point of Care Diagnostics Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Infectious Disease Point of Care Diagnostics Market Growth Strategy

Table 46. Infectious Disease Point of Care Diagnostics SWOT Analysis

Table 47. Abbott Infectious Disease Point of Care Diagnostics Product Specification

Table 48. Abbott Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Roche Infectious Disease Point of Care Diagnostics Product Specification

Table 50. Roche Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Accriva Infectious Disease Point of Care Diagnostics Product Specification

Table 52. Accriva Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Siemens Infectious Disease Point of Care Diagnostics Product Specification

Table 54. Table Siemens Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Diasorin Infectious Disease Point of Care Diagnostics Product Specification

Table 56. Diasorin Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. GE Healthcare Infectious Disease Point of Care Diagnostics Product Specification

Table 58. GE Healthcare Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. BD Infectious Disease Point of Care Diagnostics Product Specification

Table 60. BD Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. BioMerieux Infectious Disease Point of Care Diagnostics Product Specification

Table 62. BioMerieux Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Terumo Infectious Disease Point of Care Diagnostics Product Specification

Table 64. Terumo Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Specification

Table 66. Danaher Corporation Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Specification

Table 68. Eiken Chemical Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Euroimmun Infectious Disease Point of Care Diagnostics Product Specification

Table 70. Euroimmun Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Specification

Table 72. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Hologic Infectious Disease Point of Care Diagnostics Product Specification

Table 74. Hologic Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. EMD Millipore Infectious Disease Point of Care Diagnostics Product Specification

Table 76. EMD Millipore Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 77. Diaxonhit Infectious Disease Point of Care Diagnostics Product Specification

Table 78. Diaxonhit Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 79. Cavidi Infectious Disease Point of Care Diagnostics Product Specification

Table 80. Cavidi Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 81. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Specification

Table 82. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 83. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Specification

Table 84. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 85. Cepheid Infectious Disease Point of Care Diagnostics Product Specification

Table 86. Cepheid Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 87. Immunetics Infectious Disease Point of Care Diagnostics Product Specification

Table 88. Immunetics Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 89. InBios International Infectious Disease Point of Care Diagnostics Product Specification

Table 90. InBios International Infectious Disease Point of Care Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Infectious Disease Point of Care Diagnostics Production Capacity by Market Players

Table 148. Global Infectious Disease Point of Care Diagnostics Production by Market Players (2016-2021)

Table 149. Global Infectious Disease Point of Care Diagnostics Production Market Share by Market Players (2016-2021)

Table 150. Global Infectious Disease Point of Care Diagnostics Revenue by Market Players (2016-2021)

Table 151. Global Infectious Disease Point of Care Diagnostics Revenue Share by Market Players (2016-2021)

Table 152. Global Market Infectious Disease Point of Care Diagnostics Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 155. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 157. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 159. East Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 162. East Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 164. East Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 166. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 169. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 171. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 173. South Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 176. South Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 178. South Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 180. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 183. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 185. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 187. Middle East Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 190. Middle East Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 192. Middle East Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 194. Africa Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 197. Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 199. Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 201. Oceania Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 204. Oceania Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 206. Oceania Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 208. South America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 211. South America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 213. South America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 215. Rest of the World Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Infectious Disease Point of Care Diagnostics Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Infectious Disease Point of Care Diagnostics Market Share (2016-2021)

Table 218. Rest of the World Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2021)

Table 220. Rest of the World Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2021)

Table 222. North America Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 223. East Asia Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 224. Europe Infectious Disease Point of Care Diagnostics Consumption by Region (2016-2021)

Table 225. South Asia Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 226. Southeast Asia Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 227. Middle East Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 228. Africa Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 229. Oceania Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 230. South America Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 231. Rest of the World Infectious Disease Point of Care Diagnostics Consumption by Countries (2016-2021)

Table 232. Global Infectious Disease Point of Care Diagnostics Production Forecast by Region (2022-2027)

Table 233. Global Infectious Disease Point of Care Diagnostics Sales Volume Forecast by Type (2022-2027)

Table 234. Global Infectious Disease Point of Care Diagnostics Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Infectious Disease Point of Care Diagnostics Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Infectious Disease Point of Care Diagnostics Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Infectious Disease Point of Care Diagnostics Sales Price Forecast by Type (2022-2027)

Table 238. Global Infectious Disease Point of Care Diagnostics Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Infectious Disease Point of Care Diagnostics Consumption Value Forecast by Application (2022-2027)

Table 240. North America Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 241. East Asia Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 242. Europe Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 243. South Asia Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 245. Middle East Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 246. Africa Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 247. Oceania Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 248. South America Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027 by Country

Table 250. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2016-2021)

Table 252. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2022-2027)

Table 254. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2016-2021)

Table 256. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2022-2027)

Table 258. Infectious Disease Point of Care Diagnostics Distributors List

Table 259. Infectious Disease Point of Care Diagnostics Customers List





Figure 1. Product Figure

Figure 2. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2021 VS 2027

Figure 3. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2021 VS 2027

Figure 4. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 6. North America Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 7. United States Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 8. Canada Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 12. China Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 13. Japan Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 15. Europe Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 16. Europe Infectious Disease Point of Care Diagnostics Consumption Market Share by Region in 2021

Figure 17. Germany Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 19. France Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 20. Italy Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 21. Russia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 22. Spain Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 25. Poland Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 27. South Asia Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 28. India Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 30. Southeast Asia Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 31. Indonesia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 37. Middle East Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 38. Turkey Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 40. Iran Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 42. Africa Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 43. Africa Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 44. Nigeria Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 47. Oceania Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 48. Australia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 49. South America Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 50. South America Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 51. Brazil Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Infectious Disease Point of Care Diagnostics Consumption and Growth Rate

Figure 54. Rest of the World Infectious Disease Point of Care Diagnostics Consumption Market Share by Countries in 2021

Figure 55. Global Infectious Disease Point of Care Diagnostics Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Infectious Disease Point of Care Diagnostics Price and Trend Forecast (2022-2027)

Figure 58. North America Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 59. North America Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 75. South America Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Infectious Disease Point of Care Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Infectious Disease Point of Care Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 79. East Asia Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 80. Europe Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 81. South Asia Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 82. Southeast Asia Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 83. Middle East Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 84. Africa Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 85. Oceania Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 86. South America Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 87. Rest of the world Infectious Disease Point of Care Diagnostics Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Infectious Disease Point of Care Diagnostics

Figure 89. Manufacturing Process Analysis of Infectious Disease Point of Care Diagnostics

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Infectious Disease Point of Care Diagnostics Supply Chain Analysis